Skip to main content
HIV InfectionsSTIsImmune and autoimmune

What this study is

SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infection, progression, non-progression, response to treatment, control of HIV-1 virus, and evolution of drug resistance.

Study details

Sponsor
University of California, San Francisco
Conditions
HIV Infections
Enrolling
2,500 people
Starts
2000-03
Est. completion
2033-12
Record
View on ClinicalTrials.gov ↗